Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Concepts on neurological disease evolution.

R J Seitz1

  • 1Department of Neurology, University Hospital Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany. seitz@neurologie.uni-duesseldorf.de

Pharmacopsychiatry
|November 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What influence do face masks have on reading emotions in faces?

Neuroimage. Reports·2025
Same author

Intravenous levetiracetam in clinical practice--Results from an independent registry.

Seizure·2015
Same author

Reasoning about the implications of facial expressions: a behavioral and fMRI study on low and high social impact.

Brain and cognition·2014
Same author

Processing of subliminal facial expressions of emotion: a behavioral and fMRI study.

Social neuroscience·2013
Same author

A functional magnetic resonance imaging study of visuomotor processing in a virtual reality-based paradigm: Rehabilitation Gaming System.

The European journal of neuroscience·2013
Same author

The neural correlates of affect reading: an fMRI study on faces and gestures.

Behavioural brain research·2012
Same journal

Correction: Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain.

Pharmacopsychiatry·2026
Same journal

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same journal

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Pharmacopsychiatry·2026
Same journal

Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.

Pharmacopsychiatry·2026
Same journal

A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis.

Pharmacopsychiatry·2026
Same journal

High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting.

Pharmacopsychiatry·2026
See all related articles

Neurological diseases, both degenerative and relapsing, have complex mechanisms influencing their progression. Understanding these mechanisms, including genetic factors, is crucial for predicting disease evolution and developing targeted therapies.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathophysiology

Background:

  • Neurological diseases present as either progressive or relapsing-remitting, impacting affected systems.
  • Clinical evaluation and in vivo neuroimaging allow for the study of disease-specific pathology and underlying mechanisms.
  • Frequent relapsing neurological diseases include multiple sclerosis, brain infarction, and epilepsy.

Purpose of the Study:

  • To explore the mechanisms of neurological disease manifestation.
  • To discuss recent research on aetiopathogenesis and pathophysiology for therapeutic interventions and relapse prevention.
  • To highlight the challenges in predicting disease progression due to ill-defined genetic marker relations.

Main Methods:

  • Clinical evaluation of affected neurological systems.

Related Experiment Videos

  • In vivo neuroimaging for disease-specific pathology assessment.
  • Analysis of molecular genetic markers in relation to disease evolution.

    • Main Results:

    • Disease manifestation is determined by aetiopathogenesis, lesion-specific pathophysiology, and unspecific bystanders.
    • Prediction of neurological disease progression or relapse remains poor.
    • The relationship between molecular genetic markers and disease evolution is not well-defined.

    Conclusions:

    • Further research into aetiopathogenesis and pathophysiology is needed.
    • New perspectives offer potential for selective therapeutic interventions.
    • Relapse prevention strategies may be improved by a better understanding of disease mechanisms.